The Italian Multiple Sclerosis Register Experience With Cladribine

Tommaso Guerra; Massimiliano Copetti; Chiara Zanetta; Francesco Patti; Clara Grazia Chisari; Elena Barbuti; Emilio Portaccio; Matteo Foschi; Antonella Conte; Diana Ferraro; Eleonora Cocco; Roberta Fantozzi; Giorgia Teresa Maniscalco; Giuseppe Salemi; Carla Tortorella; Damiano Paolicelli; Massimo Filippi; Maria Pia Amato; María Trojano; Pietro Iaffaldano

doi:10.1212/nxi.0000000000200415

Related publications

Article2023

Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4

Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, Eleonora Cocco, Nicola De Stefano, Claudio Gasperini, Paolo Gallo, Carlo Pozzilli, María Trojano, Massimo Filippi

Article2024

Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy

Massimo Filippi, Laura Ferrè, Chiara Zanetta, Caterina Rizzi, Gabriella Pessina, Francesco Assogna, Maria A. Rocca

Preprint2025

Validation of Generative AI Techniques for Synthetic Data Generation in Multiple Sclerosis Research: A Comparison with Real-World Evidence from the Italian MS Registry

Pietro Iaffaldano, Saverio D’Amico, Giuseppe Lucisano, Massimiliano Copetti, Tommaso Guerra, Maria A. Rocca, Francesco Patti, Giovanna De Luca, Diana Ferraro, Rocco Totaro, Vincenzo Brescia Morra, Giuseppe Salemi, Emilio Portaccio, Matteo Foschi, Matilde Inglese, Maria Gabriella Coniglio, Clara Grazia Chisari, Francesca Caputo, Damiano Paolicelli, Mario Alberto Battaglia, Matteo Della Porta, Victor Savevski,

Article2001

Cladribine. Ortho Biotech Inc.

Carla Tortorella, Marco Rovaris, Massimo Filippi

Article2021

Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability

Antonio Carotenuto, Laura Cacciaguerra, Elisabetta Pagani, Paolo Preziosa, Massimo Filippi, Maria A. Rocca